STOK
Price
$11.96
Change
-$0.06 (-0.50%)
Updated
May 6, 1:49 PM EST
One day until earnings call
STRO
Price
$3.88
Change
+$0.05 (+1.31%)
Updated
May 6, 1:49 PM EST
8 days until earnings call
Ad is loading...

Compare predictions STOK vs STRO

Header iconSTOK vs STRO Comparison
Open Charts STOK vs STROBanner chart's image
Stoke Therapeutics
Price$11.96
Change-$0.06 (-0.50%)
Volume$100
CapitalizationN/A
Sutro Biopharma
Price$3.88
Change+$0.05 (+1.31%)
Volume$300
CapitalizationN/A
View a ticker or compare two or three
STOK vs STRO Comparison Chart

Loading...

STOKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
STRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
STOK vs. STRO commentary
May 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STOK is a Hold and STRO is a Buy.

COMPARISON
Comparison
May 06, 2024
Stock price -- (STOK: $12.02 vs. STRO: $3.83)
Brand notoriety: STOK and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STOK: 33% vs. STRO: 57%
Market capitalization -- STOK: $626.45M vs. STRO: $313.16M
STOK [@Biotechnology] is valued at $626.45M. STRO’s [@Biotechnology] market capitalization is $313.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $545.88B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STOK’s FA Score shows that 0 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • STOK’s FA Score: 0 green, 5 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, both STOK and STRO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STOK’s TA Score shows that 4 TA indicator(s) are bullish while STRO’s TA Score has 3 bullish TA indicator(s).

  • STOK’s TA Score: 4 bullish, 4 bearish.
  • STRO’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, STOK is a better buy in the short-term than STRO.

Price Growth

STOK (@Biotechnology) experienced а -3.14% price change this week, while STRO (@Biotechnology) price change was +11.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.95%. For the same industry, the average monthly price growth was -3.09%, and the average quarterly price growth was +64.79%.

Reported Earning Dates

STOK is expected to report earnings on Aug 05, 2024.

STRO is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+3.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for STOK with price predictions.
OPEN
A.I.dvisor published
a Summary for STRO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
STOK($626M) has a higher market cap than STRO($313M). STOK YTD gains are higher at: 128.517 vs. STRO (-10.723).
STOKSTROSTOK / STRO
Capitalization626M313M200%
EBITDAN/AN/A-
Gain YTD128.517-10.723-1,199%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
STOKSTRO
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 6 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 7 days ago
87%
Aroon
ODDS (%)
Bullish Trend 6 days ago
78%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Ad is loading...
STOKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
STRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HAONX12.430.12
+0.97%
Harbor International Core Investor
OALVX18.390.10
+0.55%
Optimum Large Cap Value A
ACIPX15.850.08
+0.51%
American Century Mid Cap Value G
FNPIX33.310.16
+0.48%
ProFunds Financials UltraSector Inv
WGICX7.160.01
+0.14%
Wasatch Micro Cap Institutional

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+2.82%
NUVB - STOK
49%
Loosely correlated
-1.53%
INZY - STOK
45%
Loosely correlated
+1.94%
QTTB - STOK
44%
Loosely correlated
-0.70%
STRO - STOK
43%
Loosely correlated
-2.79%
KOD - STOK
40%
Loosely correlated
+1.89%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with BCAB. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
-2.79%
BCAB - STRO
47%
Loosely correlated
+2.85%
ALGS - STRO
44%
Loosely correlated
-4.24%
STOK - STRO
43%
Loosely correlated
+2.82%
ALLO - STRO
40%
Loosely correlated
+3.37%
INZY - STRO
39%
Loosely correlated
+1.94%
More